Ocugen Inc
General ticker "OCGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $253.8M
Ocugen Inc follows the US Stock Market performance with the rate: 18.7%.
Estimated limits based on current volatility of 4.2%: low 0.74$, high 0.81$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.25$, 0.87$]
- 2024-12-30 to 2025-12-30 estimated range: [0.37$, 1.12$]
Financial Metrics affecting the OCGN estimates:
- Negative: Non-GAAP EPS, $ of -0.33 <= 0.10
- Negative: Operating profit margin, % of -91.57 <= 1.03
- Negative: Operating cash flow per share per price, % of -39.20 <= 2.35
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term OCGN quotes
Long-term OCGN plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $6.04MM |
Operating Expenses | $58.03MM | $84.87MM | $71.57MM |
Operating Income | $-58.03MM | $-84.87MM | $-65.53MM |
Non-Operating Income | $-0.39MM | $3.52MM | $2.45MM |
Interest Expense | $0.08MM | $0.00MM | $0.00MM |
R&D Expense | $35.11MM | $49.76MM | $39.57MM |
Income(Loss) | $-58.42MM | $-81.35MM | $-63.08MM |
Taxes | $-0.05MM | $0.00MM | $0.00MM |
Profit(Loss) | $-58.37MM | $-81.35MM | $-63.08MM |
Stockholders Equity | $95.82MM | $84.05MM | $40.56MM |
Assets | $105.76MM | $108.63MM | $64.55MM |
Operating Cash Flow | $-47.94MM | $-60.08MM | $-62.05MM |
Capital expenditure | $0.94MM | $4.46MM | $10.48MM |
Investing Cash Flow | $-1.82MM | $-16.97MM | $3.08MM |
Financing Cash Flow | $120.68MM | $59.48MM | $20.88MM |
Earnings Per Share* | $-0.30 | $-0.36 | $-0.26 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.